Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence. 1998

M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
Division of Medical Genetics, University of Geneva Medical School and Cantonal Hospital of Geneva, Switzerland.

Cyclic nucleotide-specific phosphodiesterases (PDEs) play an essential role in signal transduction by regulating the intracellular concentration of second messengers (cAMP and cGMP). We have identified and made an initial characterization of a full-length cDNA encoding a novel human cyclic nucleotide phosphodiesterase, PDE9A. At least four different mRNA transcripts (PDE9A1, A2, A3, A4) are produced as a result of alternative splicing of 5' exons, potentially changing the N-terminal amino acid sequences of the encoded proteins. All these predicted proteins would contain a 3',5'-cyclic nucleotide phosphodiesterase signature motif (Prosite no. PDOC00116). Northern blot analysis revealed several mRNA species of approximately 2.4 kb with varying expression patterns and intensities in most tissues examined, except blood. We have also isolated the mouse homolog of the human PDE9A2 mRNA transcript, pde9A2. The human and mouse isoforms have 93 and 83% sequence identity at the amino acid and nucleotide levels, respectively. PDE9A was mapped to 21q22.3, between TFF1 and D21S360. Comparison of the PDE9A1 cDNA with the genomic sequence from the region revealed that the gene is split into 20 exons that extend over 122 kb. Comparison of the physical map of the region and the genomic sequence further refines the mapping, with D21S113 being derived from intron 15. Several genetic disorders map to 21q22.3, including one form of bipolar affective disorder. Since functional disturbances in intraneuronal signal transmission via second messengers play an important role in the pathophysiology of affective disorders, PDE9A is a strong candidate for such a role by position and function.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015105 3',5'-Cyclic-AMP Phosphodiesterases Enzymes that catalyze the hydrolysis of CYCLIC AMP to form adenosine 5'-phosphate. The enzymes are widely distributed in animal tissue and control the level of intracellular cyclic AMP. Many specific enzymes classified under this heading demonstrate additional spcificity for 3',5'-cyclic IMP and CYCLIC GMP. 3',5'-Cyclic AMP 5'-Nucleotidohydrolase,3',5'-Cyclic-Nucleotide Phosphodiesterase,CAMP Phosphodiesterase,3',5' Cyclic AMP Phosphodiesterase,3',5'-Cyclic AMP Phosphodiesterase,3',5'-Cyclic Nucleotide Phosphodiesterase,3',5'-Cyclic-AMP Phosphodiesterase,3',5'-Nucleotide Phosphodiesterase,3,5-Cyclic AMP 5-Nucleotidohydrolase,3,5-Cyclic AMP Phosphodiesterase,3',5' Cyclic AMP 5' Nucleotidohydrolase,3',5' Cyclic AMP Phosphodiesterases,3',5' Cyclic Nucleotide Phosphodiesterase,3',5' Nucleotide Phosphodiesterase,3,5 Cyclic AMP 5 Nucleotidohydrolase,3,5 Cyclic AMP Phosphodiesterase,5'-Nucleotidohydrolase, 3',5'-Cyclic AMP,5-Nucleotidohydrolase, 3,5-Cyclic AMP,AMP 5'-Nucleotidohydrolase, 3',5'-Cyclic,AMP 5-Nucleotidohydrolase, 3,5-Cyclic,AMP Phosphodiesterase, 3',5'-Cyclic,AMP Phosphodiesterase, 3,5-Cyclic,Nucleotide Phosphodiesterase, 3',5'-Cyclic,Phosphodiesterase, 3',5'-Cyclic AMP,Phosphodiesterase, 3',5'-Cyclic Nucleotide,Phosphodiesterase, 3',5'-Cyclic-AMP,Phosphodiesterase, 3',5'-Cyclic-Nucleotide,Phosphodiesterase, 3',5'-Nucleotide,Phosphodiesterase, 3,5-Cyclic AMP,Phosphodiesterase, CAMP,Phosphodiesterases, 3',5'-Cyclic-AMP
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D016415 Sequence Alignment The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms. Sequence Homology Determination,Determination, Sequence Homology,Alignment, Sequence,Alignments, Sequence,Determinations, Sequence Homology,Sequence Alignments,Sequence Homology Determinations
D017398 Alternative Splicing A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different. RNA Splicing, Alternative,Splicing, Alternative,Alternate Splicing,Nested Transcripts,Alternate Splicings,Alternative RNA Splicing,Alternative RNA Splicings,Alternative Splicings,Nested Transcript,RNA Splicings, Alternative,Splicing, Alternate,Splicing, Alternative RNA,Splicings, Alternate,Splicings, Alternative,Splicings, Alternative RNA,Transcript, Nested,Transcripts, Nested

Related Publications

M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
January 1996, The Journal of biological chemistry,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
August 1990, Biochemical and biophysical research communications,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
February 1991, Gene,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
February 1994, Molecular immunology,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
January 1992, Growth factors (Chur, Switzerland),
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
April 1991, Oncogene,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
August 1999, Molecular human reproduction,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
June 1998, The Journal of biological chemistry,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
June 1997, Biochemical and biophysical research communications,
M Guipponi, and H S Scott, and J Kudoh, and K Kawasaki, and K Shibuya, and A Shintani, and S Asakawa, and H Chen, and M D Lalioti, and C Rossier, and S Minoshima, and N Shimizu, and S E Antonarakis
September 1991, The Journal of biological chemistry,
Copied contents to your clipboard!